Global Radiopharmaceuticals in Nuclear Medicine Market Analysis 2016-2020 and Forecast 2021-2026

Table of Contents
1 Industry Overview
1.1 Radiopharmaceuticals in Nuclear Medicine Industry
Figure Radiopharmaceuticals in Nuclear Medicine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Radiopharmaceuticals in Nuclear Medicine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Radiopharmaceuticals in Nuclear Medicine
1.2.2 Downstream
Table Application Segment of Radiopharmaceuticals in Nuclear Medicine
Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Radiopharmaceuticals in Nuclear Medicine Market by Type
3.1 By Type
3.1.1 Diagnostic Radiopharmaceuticals
Table Major Company List of Diagnostic Radiopharmaceuticals
3.1.2 Therapy Radiopharmaceuticals
Table Major Company List of Therapy Radiopharmaceuticals
3.1.3 Enriched Stable Isotopes
Table Major Company List of Enriched Stable Isotopes
3.2 Market Size
Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Type, in USD Million
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2016-2020, by Type, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Type, in Volume
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Type, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Bracco Imaging S.P.A. (Company Profile, Sales Data etc.)
4.1.1 Bracco Imaging S.P.A. Profile
Table Bracco Imaging S.P.A. Overview List
4.1.2 Bracco Imaging S.P.A. Products & Services
4.1.3 Bracco Imaging S.P.A. Business Operation Conditions
Table Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Cambridge Isotope Laboratories, Inc. (Company Profile, Sales Data etc.)
4.2.1 Cambridge Isotope Laboratories, Inc. Profile
Table Cambridge Isotope Laboratories, Inc. Overview List
4.2.2 Cambridge Isotope Laboratories, Inc. Products & Services
4.2.3 Cambridge Isotope Laboratories, Inc. Business Operation Conditions
Table Business Operation of Cambridge Isotope Laboratories, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Cardinal Health, Inc. (Company Profile, Sales Data etc.)
4.3.1 Cardinal Health, Inc. Profile
Table Cardinal Health, Inc. Overview List
4.3.2 Cardinal Health, Inc. Products & Services
4.3.3 Cardinal Health, Inc. Business Operation Conditions
Table Business Operation of Cardinal Health, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Covidien, Plc (Company Profile, Sales Data etc.)
4.4.1 Covidien, Plc Profile
Table Covidien, Plc Overview List
4.4.2 Covidien, Plc Products & Services
4.4.3 Covidien, Plc Business Operation Conditions
Table Business Operation of Covidien, Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Eczacibasi-Monrol (Company Profile, Sales Data etc.)
4.5.1 Eczacibasi-Monrol Profile
Table Eczacibasi-Monrol Overview List
4.5.2 Eczacibasi-Monrol Products & Services
4.5.3 Eczacibasi-Monrol Business Operation Conditions
Table Business Operation of Eczacibasi-Monrol (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Fujifilm Holdings Corporation (Company Profile, Sales Data etc.)
4.6.1 Fujifilm Holdings Corporation Profile
Table Fujifilm Holdings Corporation Overview List
4.6.2 Fujifilm Holdings Corporation Products & Services
4.6.3 Fujifilm Holdings Corporation Business Operation Conditions
Table Business Operation of Fujifilm Holdings Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 GE Healthcare (Subsidiary Of General Electric Company) (Company Profile, Sales Data etc.)
4.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profile
Table GE Healthcare (Subsidiary Of General Electric Company) Overview List
4.7.2 GE Healthcare (Subsidiary Of General Electric Company) Products & Services
4.7.3 GE Healthcare (Subsidiary Of General Electric Company) Business Operation Conditions
Table Business Operation of GE Healthcare (Subsidiary Of General Electric Company) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 IBA Group (Company Profile, Sales Data etc.)
4.8.1 IBA Group Profile
Table IBA Group Overview List
4.8.2 IBA Group Products & Services
4.8.3 IBA Group Business Operation Conditions
Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Isotec, Inc. (Sigma-Aldrich) (Company Profile, Sales Data etc.)
4.9.1 Isotec, Inc. (Sigma-Aldrich) Profile
Table Isotec, Inc. (Sigma-Aldrich) Overview List
4.9.2 Isotec, Inc. (Sigma-Aldrich) Products & Services
4.9.3 Isotec, Inc. (Sigma-Aldrich) Business Operation Conditions
Table Business Operation of Isotec, Inc. (Sigma-Aldrich) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Lantheus Medical Imaging, Inc. (Company Profile, Sales Data etc.)
4.10.1 Lantheus Medical Imaging, Inc. Profile
Table Lantheus Medical Imaging, Inc. Overview List
4.10.2 Lantheus Medical Imaging, Inc. Products & Services
4.10.3 Lantheus Medical Imaging, Inc. Business Operation Conditions
Table Business Operation of Lantheus Medical Imaging, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Nordion, Inc. (Company Profile, Sales Data etc.)
4.11.1 Nordion, Inc. Profile
Table Nordion, Inc. Overview List
4.11.2 Nordion, Inc. Products & Services
4.11.3 Nordion, Inc. Business Operation Conditions
Table Business Operation of Nordion, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Ntp Radioisotopes (Pty), Ltd. (Company Profile, Sales Data etc.)
4.12.1 Ntp Radioisotopes (Pty), Ltd. Profile
Table Ntp Radioisotopes (Pty), Ltd. Overview List
4.12.2 Ntp Radioisotopes (Pty), Ltd. Products & Services
4.12.3 Ntp Radioisotopes (Pty), Ltd. Business Operation Conditions
Table Business Operation of Ntp Radioisotopes (Pty), Ltd. (Sales Revenue, Cost, Gross Margin)
4.13 Siemens Healthcare (Subsidiary Of Siemens AG) (Company Profile, Sales Data etc.)
4.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Profile
Table Siemens Healthcare (Subsidiary Of Siemens AG) Overview List
4.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Products & Services
4.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Business Operation Conditions
Table Business Operation of Siemens Healthcare (Subsidiary Of Siemens AG) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Taiyo Nippon Sanso Corporation (Company Profile, Sales Data etc.)
4.14.1 Taiyo Nippon Sanso Corporation Profile
Table Taiyo Nippon Sanso Corporation Overview List
4.14.2 Taiyo Nippon Sanso Corporation Products & Services
4.14.3 Taiyo Nippon Sanso Corporation Business Operation Conditions
Table Business Operation of Taiyo Nippon Sanso Corporation (Sales Revenue, Cost, Gross Margin)
4.15 Urenco Limited (Company Profile, Sales Data etc.)
4.15.1 Urenco Limited Profile
Table Urenco Limited Overview List
4.15.2 Urenco Limited Products & Services
4.15.3 Urenco Limited Business Operation Conditions
Table Business Operation of Urenco Limited (Sales Revenue, Cost, Gross Margin)
4.16 Rotem Industries, Ltd., Inc. (Company Profile, Sales Data etc.)
4.16.1 Rotem Industries, Ltd., Inc. Profile
Table Rotem Industries, Ltd., Inc. Overview List
4.16.2 Rotem Industries, Ltd., Inc. Products & Services
4.16.3 Rotem Industries, Ltd., Inc. Business Operation Conditions
Table Business Operation of Rotem Industries, Ltd., Inc. (Sales Revenue, Cost, Gross Margin)
4.17 Australian Nuclear Association And Technology Organization (ANSTO) (Company Profile, Sales Data etc.)
4.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Profile
Table Australian Nuclear Association And Technology Organization (ANSTO) Overview List
4.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Products & Services
4.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Business Operation Conditions
Table Business Operation of Australian Nuclear Association And Technology Organization (ANSTO) (Sales Revenue, Cost, Gross Margin)
4.18 Board of Radiation And Isotope Technology (BRIT) (Company Profile, Sales Data etc.)
4.18.1 Board of Radiation And Isotope Technology (BRIT) Profile
Table Board of Radiation And Isotope Technology (BRIT) Overview List
4.18.2 Board of Radiation And Isotope Technology (BRIT) Products & Services
4.18.3 Board of Radiation And Isotope Technology (BRIT) Business Operation Conditions
Table Business Operation of Board of Radiation And Isotope Technology (BRIT) (Sales Revenue, Cost, Gross Margin)
4.19 Institute of Atomic Energy Polatom Radioisotope Centre (Company Profile, Sales Data etc.)
4.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Profile
Table Institute of Atomic Energy Polatom Radioisotope Centre Overview List
4.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Products & Services
4.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Business Operation Conditions
Table Business Operation of Institute of Atomic Energy Polatom Radioisotope Centre (Sales Revenue, Cost, Gross Margin)
4.20 Institute of Isotopes Co., Ltd. (Company Profile, Sales Data etc.)
4.20.1 Institute of Isotopes Co., Ltd. Profile
Table Institute of Isotopes Co., Ltd. Overview List
4.20.2 Institute of Isotopes Co., Ltd. Products & Services
4.20.3 Institute of Isotopes Co., Ltd. Business Operation Conditions
Table Business Operation of Institute of Isotopes Co., Ltd. (Sales Revenue, Cost, Gross Margin)
4.21 Institute Of Radioelement (IRE) (Company Profile, Sales Data etc.)
4.21.1 Institute Of Radioelement (IRE) Profile
Table Institute Of Radioelement (IRE) Overview List
4.21.2 Institute Of Radioelement (IRE) Products & Services
4.21.3 Institute Of Radioelement (IRE) Business Operation Conditions
Table Business Operation of Institute Of Radioelement (IRE) (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue 2016-2020, by Company, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share in 2020, by Company, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume 2016-2020, by Company, in Volume
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Market Concentration, in 2020
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine MMarket Concentration, in 2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Diagnostic Application
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Diagnostic Application, 2016-2020, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Diagnostic Application, 2016-2020, in Volume
6.1.2 Demand in Therapeutic Application
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Therapeutic Application, 2016-2020, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Therapeutic Application, 2016-2020, in Volume
6.1.3 Demand in Research
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Research, 2016-2020, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Research, 2016-2020, in Volume
6.1.4 Demand in Pharmaceutical
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Pharmaceutical, 2016-2020, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Pharmaceutical, 2016-2020, in Volume
6.1.5 Demand in Others
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Others, 2016-2020, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Radiopharmaceuticals in Nuclear Medicine Demand Forecast 2021-2026, by Application, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Market Growth 2021-2026, by Application, in USD Million
Figure Radiopharmaceuticals in Nuclear Medicine Market Share in 2026, by Application, in USD Million
Table Radiopharmaceuticals in Nuclear Medicine Demand Forecast 2021-2026, by Application, in Volume
Table Radiopharmaceuticals in Nuclear Medicine Market Growth 2021-2026, by Application, in Volume
Table Radiopharmaceuticals in Nuclear Medicine Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Radiopharmaceuticals in Nuclear Medicine Production 2016-2020, by Region, in USD Million
Table Radiopharmaceuticals in Nuclear Medicine Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Region, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share 2016-2020, by Region, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Region, in Volume
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
Table North America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
Table South America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Region, in USD Million
Table Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of Radiopharmaceuticals in Nuclear Medicine
2. Table Application Segment of Radiopharmaceuticals in Nuclear Medicine
3. Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Therapy Radiopharmaceuticals
5. Table Major Company List of Enriched Stable Isotopes
6. Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Type, in USD Million
7. Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Type, in Volume
8. Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Type, in Volume
10. Table Bracco Imaging S.P.A. Overview List
11. Table Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Cambridge Isotope Laboratories, Inc. Overview List
13. Table Business Operation of Cambridge Isotope Laboratories, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Cardinal Health, Inc. Overview List
15. Table Business Operation of Cardinal Health, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Covidien, Plc Overview List
17. Table Business Operation of Covidien, Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Eczacibasi-Monrol Overview List
19. Table Business Operation of Eczacibasi-Monrol (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Fujifilm Holdings Corporation Overview List
21. Table Business Operation of Fujifilm Holdings Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table GE Healthcare (Subsidiary Of General Electric Company) Overview List
23. Table Business Operation of GE Healthcare (Subsidiary Of General Electric Company) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table IBA Group Overview List
25. Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Isotec, Inc. (Sigma-Aldrich) Overview List
27. Table Business Operation of Isotec, Inc. (Sigma-Aldrich) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Lantheus Medical Imaging, Inc. Overview List
29. Table Business Operation of Lantheus Medical Imaging, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Nordion, Inc. Overview List
31. Table Business Operation of Nordion, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Ntp Radioisotopes (Pty), Ltd. Overview List
33. Table Business Operation of Ntp Radioisotopes (Pty), Ltd. (Sales Revenue, Cost, Gross Margin)
34. Table Siemens Healthcare (Subsidiary Of Siemens AG) Overview List
35. Table Business Operation of Siemens Healthcare (Subsidiary Of Siemens AG) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Taiyo Nippon Sanso Corporation Overview List
37. Table Business Operation of Taiyo Nippon Sanso Corporation (Sales Revenue, Cost, Gross Margin)
38. Table Urenco Limited Overview List
39. Table Business Operation of Urenco Limited (Sales Revenue, Cost, Gross Margin)
40. Table Rotem Industries, Ltd., Inc. Overview List
41. Table Business Operation of Rotem Industries, Ltd., Inc. (Sales Revenue, Cost, Gross Margin)
42. Table Australian Nuclear Association And Technology Organization (ANSTO) Overview List
43. Table Business Operation of Australian Nuclear Association And Technology Organization (ANSTO) (Sales Revenue, Cost, Gross Margin)
44. Table Board of Radiation And Isotope Technology (BRIT) Overview List
45. Table Business Operation of Board of Radiation And Isotope Technology (BRIT) (Sales Revenue, Cost, Gross Margin)
46. Table Institute of Atomic Energy Polatom Radioisotope Centre Overview List
47. Table Business Operation of Institute of Atomic Energy Polatom Radioisotope Centre (Sales Revenue, Cost, Gross Margin)
48. Table Institute of Isotopes Co., Ltd. Overview List
49. Table Business Operation of Institute of Isotopes Co., Ltd. (Sales Revenue, Cost, Gross Margin)
50. Table Institute Of Radioelement (IRE) Overview List
51. Table Business Operation of Institute Of Radioelement (IRE) (Sales Revenue, Cost, Gross Margin)
52. Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue 2016-2020, by Company, in USD Million
53. Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share 2016-2020, by Company, in USD Million
54. Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume 2016-2020, by Company, in Volume
55. Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share 2016-2020, by Company, in Volume
56. Table Regional Demand Comparison List
57. Table Major Application in Different Regions
58. Table Radiopharmaceuticals in Nuclear Medicine Demand Forecast 2021-2026, by Application, in USD Million
59. Table Radiopharmaceuticals in Nuclear Medicine Demand Forecast 2021-2026, by Application, in Volume
60. Table Radiopharmaceuticals in Nuclear Medicine Market Growth 2021-2026, by Application, in Volume
61. Table Radiopharmaceuticals in Nuclear Medicine Market Share in 2026, by Application, in Volume
62. Table Radiopharmaceuticals in Nuclear Medicine Production 2016-2020, by Region, in USD Million
63. Table Radiopharmaceuticals in Nuclear Medicine Production 2016-2020, by Region, in Volume
64. Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Region, in USD Million
65. Table Global Radiopharmaceuticals in Nuclear Medicine Market Share 2016-2020, by Region, in USD Million
66. Table Global Radiopharmaceuticals in Nuclear Medicine Market 2016-2020, by Region, in Volume
67. Table Global Radiopharmaceuticals in Nuclear Medicine Market Share 2016-2020, by Region, in Volume
68. Table North America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
69. Table North America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
70. Table Europe Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
71. Table Europe Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
72. Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
73. Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
74. Table South America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
75. Table South America Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
76. Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in USD Million
77. Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size 2016-2020, by Country, in Volume
78. Table Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Region, in USD Million
79. Table Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026, by Region, in Volume
80. Table Price Factors List

List of Figure
1. Figure Radiopharmaceuticals in Nuclear Medicine Industry Chain Structure
2. Figure Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2016-2020, by Type, in Volume
4. Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
7. Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Market Concentration, in 2020
8. Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine MMarket Concentration, in 2020
9. Figure South America Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
10. Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Concentration, in 2020
11. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Diagnostic Application, 2016-2020, in USD Million
12. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Diagnostic Application, 2016-2020, in Volume
13. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Therapeutic Application, 2016-2020, in USD Million
14. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Therapeutic Application, 2016-2020, in Volume
15. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Research, 2016-2020, in USD Million
16. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Research, 2016-2020, in Volume
17. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Pharmaceutical, 2016-2020, in USD Million
18. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Pharmaceutical, 2016-2020, in Volume
19. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Others, 2016-2020, in USD Million
20. Figure Radiopharmaceuticals in Nuclear Medicine Demand in Others, 2016-2020, in Volume
21. Figure Radiopharmaceuticals in Nuclear Medicine Market Growth 2021-2026, by Application, in USD Million
22. Figure Radiopharmaceuticals in Nuclear Medicine Market Share in 2026, by Application, in USD Million
23. Figure North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
24. Figure North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
25. Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
26. Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
27. Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
28. Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
29. Figure South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
30. Figure South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
31. Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in USD Million
32. Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth 2016-2020, in Volume
33. Figure Marketing Channels Overview